Drug intelligence / Profile preview

Quban Powder

Development stage: Preclinical
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

**Quban Powder** is an investigational traditional Chinese medicine powder being studied by Guang'anmen Hospital, China Academy of Chinese Medical Sciences, for **melasma**. It was evaluated in the retrospective ChiCTR-registered study ChiCTR2300076869, which investigates melasma treatment under a traditional Chinese medicine theory of promoting blood circulation and removing stasis, with hydroquinone as a comparator. Its individual herbal constituents, manufacturing specifications, route, and molecular mechanism have not been publicly specified in the available registry record.

Other names: Quban Powder祛斑散

Beyond the preview

Go deeper on Quban Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quban Powder.

Explore the full profile